SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-287309
Filing Date
2020-11-06
Accepted
2020-11-06 06:06:29
Documents
3
Period of Report
2020-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39629d8k.htm 8-K 17819
2 EX-99.1 d39629dex991.htm EX-99.1 13765
3 GRAPHIC g39629g1106084244308.jpg GRAPHIC 4954
  Complete submission text file 0001193125-20-287309.txt   39924
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Filer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39059 | Film No.: 201292288
SIC: 3841 Surgical & Medical Instruments & Apparatus